Tvardi Therapeutics, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -8.9% | -81.7% | -40.1% | +62.3% | -26.8% | |
| – | -11.2% | -74.5% | -40.7% | +67.5% | -28.0% | |
| – | -57.5% | +59.7% | +6.7% | +65.4% | -45.3% | |
| – | -7.7% | -73.8% | -47.6% | +65.4% | -18.7% | |
| – | -44.2% | +286.5% | -9.8% | +11.9% | – | |
| – | – | – | – | – | – | |
| – | – | – | -12.3% | -14.1% | -16.4% | |
| – | -11.8% | +361.5% | -1.2% | -45.6% | -77.0% | |
| – | -4.7% | -75.7% | -23.3% | +21.1% | +178.0% | |
| – | +9.6% | +14.0% | -95.4% | – | – | |
| – | +15.0% | -57.2% | -33.1% | -11.0% | +124.5% | |
| – | – | – | – | – | – | |
| – | -8.6% | -119.8% | – | – | – | |
| – | – | – | – | – | – | |
| – | +5.9% | +564.1% | +0.0% | -83.7% | +411.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.